Evidence map›Paper›PMID 34084116›Full record

ArticleCurrent urology2021

Bladder preservation versus radical cystectomy in transitional cell carcinoma and squamous cell carcinoma muscle invasive bladder cancer.

Dalia O Mohamed, Mona M Sayed, Islam F Abdelkawi, Mahmoud H Elshoieby, Salah M Khallaf, Lamia M Khallaf, Doaa M Fouad

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dalia O MohamedRadiation Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Mona M SayedRadiation Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Islam F AbdelkawiSurgical Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Mahmoud H ElshoiebyUrology Department, Assiut University, Assiut, Egypt.
Salah M KhallafMedical Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Lamia M KhallafRadiodiagnosis Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Doaa M FouadRadiodiagnosis Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Assiut University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRandomizing patients to bladder preservation or radical cystectomy (RC) for the treatment of bladder cancer has not been practical, due to patient and physician preferences. Therefore, continually comparing the 2 treatment modalities is needed, in order to make the proper choice for each patient. PATIENTS AND

methodsThe records of T1-4N0M0 bladder cancer patients, who presented to the South Egypt Cancer Institute between 2007 and 2017 and were treated by either bladder preservation or RC were reviewed.

resultsOut of the 166 included patients, 81 (48.8%) patients were treated by bladder preservation and 85 (51.2%) patients had RC. For the patients treated by bladder preservation and the patients treated by RC, the 5-year overall survival (OS) was 56% and 60% (

conclusionBladder preservation is a safe alternative to cystectomy in transitional cell carcinoma stages T1-4aN0M0, and its use in SCC bladder cancer should be further studied, as it could be feasible to spare them from initial cystectomy.

Indexed as

Bladder cancerCystectomyPreservationSquamous cell carcinomaTransitional cell carcinoma

Identifiers

PMID34084116
PMCPMC8137092
OpenAlexW3149105743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.